H Thadepalli

1.6k total citations
60 papers, 1.2k citations indexed

About

H Thadepalli is a scholar working on Pharmacology, Clinical Biochemistry and Surgery. According to data from OpenAlex, H Thadepalli has authored 60 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pharmacology, 17 papers in Clinical Biochemistry and 16 papers in Surgery. Recurrent topics in H Thadepalli's work include Antibiotics Pharmacokinetics and Efficacy (19 papers), Bacterial Identification and Susceptibility Testing (17 papers) and Antibiotic Resistance in Bacteria (13 papers). H Thadepalli is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (19 papers), Bacterial Identification and Susceptibility Testing (17 papers) and Antibiotic Resistance in Bacteria (13 papers). H Thadepalli collaborates with scholars based in United States, India and Belarus. H Thadepalli's co-authors include S. L. Gorbach, John G. Bartlett, Vinod K. Dhawan, S Gollapudi, A B Onderdonk, James W. Mayhew, B. Dharma Rao, Michael Bishop, Harry B. Kram and Gary J. Ordog and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Clinical Infectious Diseases.

In The Last Decade

H Thadepalli

58 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H Thadepalli United States 16 338 328 255 229 222 60 1.2k
Haragopal Thadepalli United States 19 495 1.5× 425 1.3× 407 1.6× 307 1.3× 252 1.1× 72 1.6k
A.‐S. Malmborg Sweden 20 230 0.7× 361 1.1× 255 1.0× 119 0.5× 132 0.6× 71 1.3k
M. P. Glauser Switzerland 16 126 0.4× 674 2.1× 315 1.2× 167 0.7× 236 1.1× 26 1.5k
R P Wenzel United States 16 347 1.0× 511 1.6× 150 0.6× 164 0.7× 169 0.8× 26 1.3k
Hanna N. Canawati United States 16 285 0.8× 398 1.2× 380 1.5× 185 0.8× 199 0.9× 32 1.3k
Harry N. Beaty United States 20 168 0.5× 590 1.8× 399 1.6× 203 0.9× 181 0.8× 37 1.5k
Paul B. Iannini United States 22 137 0.4× 625 1.9× 424 1.7× 257 1.1× 514 2.3× 43 1.6k
Brian E. Scully United States 24 234 0.7× 489 1.5× 361 1.4× 138 0.6× 117 0.5× 49 1.4k
D. Daneau Belgium 20 134 0.4× 505 1.5× 309 1.2× 149 0.7× 344 1.5× 53 1.6k
C. Ruef Switzerland 19 229 0.7× 600 1.8× 491 1.9× 250 1.1× 246 1.1× 49 1.6k

Countries citing papers authored by H Thadepalli

Since Specialization
Citations

This map shows the geographic impact of H Thadepalli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Thadepalli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Thadepalli more than expected).

Fields of papers citing papers by H Thadepalli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H Thadepalli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Thadepalli. The network helps show where H Thadepalli may publish in the future.

Co-authorship network of co-authors of H Thadepalli

This figure shows the co-authorship network connecting the top 25 collaborators of H Thadepalli. A scholar is included among the top collaborators of H Thadepalli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H Thadepalli. H Thadepalli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thadepalli, H. (2000). Evaluation of trovafloxacin in the treatment of Klebsiella pneumoniae lung infection in tumour-bearing mice. Journal of Antimicrobial Chemotherapy. 45(1). 69–75. 3 indexed citations
2.
Thadepalli, H, et al.. (1997). In vivo efficacy of trovafloxacin (CP-99,217), a new quinolone, in experimental intra-abdominal abscesses caused by Bacteroides fragilis and Escherichia coli. Antimicrobial Agents and Chemotherapy. 41(3). 583–586. 28 indexed citations
3.
Gollapudi, S, Vikas Soni, H Thadepalli, & Sudhir Gupta. (1995). Role of Protein KinaseßIsozyme in Multidrug Resistance in Murine Leukemia P388/ADR Cells. Journal of Chemotherapy. 7(2). 157–159. 5 indexed citations
4.
Bishop, Michael, William C. Shoemaker, PAUL L. APPEL, et al.. (1995). Prospective, Randomized Trial of Survivor Values of Cardiac Index, Oxygen Delivery, and Oxygen Consumption as Resuscitation Endpoints in Severe Trauma. PubMed. 38(5). 780–787. 227 indexed citations
5.
Esposito, Silvano, et al.. (1991). Enoxacin Therapy for Experimental Pseudomonas Keratitis. Journal of Chemotherapy. 3(3). 147–151. 6 indexed citations
6.
Thadepalli, H, et al.. (1991). Ciprofloxacin monotherapy for acute pelvic infections: a comparison with clindamycin plus gentamicin.. PubMed. 78(4). 696–702. 21 indexed citations
7.
Thadepalli, H, D Mathai, Seng‐Kee Chuah, & Meena B. Bansal. (1989). Ciprofloxacin versus Ceftazidime in Skin and Soft Tissue Infections. Journal of Chemotherapy. 1(1). 30–34. 4 indexed citations
8.
Thadepalli, H, et al.. (1988). Ciprofloxacin: In Vitro, Experimental, and Clinical Evaluation. Clinical Infectious Diseases. 10(3). 505–515. 26 indexed citations
9.
Gollapudi, S, Ajay Gupta, H Thadepalli, & A. Pulido‐Pérez. (1988). Use of lymphokines in treatment of experimental intra-abdominal abscess caused by Bacteroides fragilis. Infection and Immunity. 56(9). 2369–2372. 10 indexed citations
10.
Thadepalli, H, et al.. (1986). Antibiotic levels in the small intestine.. PubMed. 163(6). 561–7. 2 indexed citations
11.
Thadepalli, H, et al.. (1985). Comparison of cefamandole and carbenicillin in preventing sepsis following penetrating abdominal trauma.. PubMed. 51(10). 580–6. 5 indexed citations
12.
Dhawan, Vinod K., et al.. (1983). Polymicrobial septicemia after liver biopsy.. PubMed. 139(3). 376–8. 1 indexed citations
13.
Dhawan, Vinod K. & H Thadepalli. (1982). Clindamycin: A Review of Fifteen Years of Experience. Clinical Infectious Diseases. 4(6). 1133–1153. 61 indexed citations
14.
Thadepalli, H, et al.. (1979). Cefoxitin Therapy for Bacterial Endocarditis. Clinical Infectious Diseases. 1(1). 170–174. 6 indexed citations
15.
Thadepalli, H & David Webb. (1979). Diagnosis and treatment of anaerobic lung infections.. PubMed. 51(6). 327–30, 334. 2 indexed citations
16.
Thadepalli, H, et al.. (1979). Clinical evaluation of mezlocillin. Antimicrobial Agents and Chemotherapy. 16(5). 605–610. 11 indexed citations
17.
Thadepalli, H & B. Dharma Rao. (1979). Actinomyces viscosus infections of the chest in humans.. PubMed. 120(1). 203–6. 14 indexed citations
18.
Thadepalli, H, et al.. (1978). Antimicrobial effect of amniotic fluid.. PubMed. 52(2). 198–204. 40 indexed citations
19.
Thadepalli, H, S. L. Gorbach, & John G. Bartlett. (1977). Apparent failure of chloramphenicol in the treatment of anaerobic infections. 22(3). 421–426. 30 indexed citations
20.
Thadepalli, H, et al.. (1975). Isolation of Clostridium in Human Infections: Evaluation of 114 Cases. The Journal of Infectious Diseases. 131(Supplement). S81–S85. 165 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026